Quick Takeaways
- Steven Frank has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $5,978,494.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Steven Frank
- Location
- Germantown, MD
- Summary
- The estimated net worth of Steven Frank is at least $5,978,494 dollars as of 16 Mar 2026. Steven Frank is the Director of PRECIGEN, INC. and owns shares of PRECIGEN, INC. (PGEN) stock worth about $5.81M. Steven Frank is the Director of BIOCRYST PHARMACEUTICALS INC and owns shares of BIOCRYST PHARMACEUTICALS INC (BCRX) stock worth about $165.4K.
- Signature
- /s/ Steven Frank, by Donald P. Lehr, as attorney-in-fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Steven Frank and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: PRECIGEN, INC. ($5,813,093).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Steven Frank
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| PGEN | PRECIGEN, INC. | Director | $5,813,093 | 13 Mar 2026 | ||
| BCRX | BIOCRYST PHARMACEUTICALS INC | Director | $165,401 | 27 Feb 2026 |
Insider Transactions Reported by Steven Frank:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.